| 1 | Differential specificity of <scp>SARS‐CoV</scp>‐2 main protease variants on peptide versus protein‐based substrates | 5.5 | 0 | Citations (PDF) |
| 2 | Evolution of Caspases and the Invention of Pyroptosis | 4.5 | 3 | Citations (PDF) |
| 3 | Cell organelles are retained inside pyroptotic corpses during inflammatory cell death | 3.9 | 1 | Citations (PDF) |
| 4 | Caspase mechanisms in the regulation of inflammation | 9.3 | 18 | Citations (PDF) |
| 5 | Resurrection of an ancient inflammatory locus reveals switch to caspase-1 specificity on a caspase-4 scaffold | 2.3 | 6 | Citations (PDF) |
| 6 | Gain of function of a metalloproteinase associated with multiple myeloma, bicuspid aortic valve, and Von Hippel Lindau syndrome. | 3.9 | 1 | Citations (PDF) |
| 7 | Engineering caspase 7 as an affinity reagent to capture proteolytic products | 5.5 | 0 | Citations (PDF) |
| 8 | Evaluation of the effects of phosphorylation of synthetic peptide substrates on their cleavage by caspase-3 and -7 | 3.9 | 6 | Citations (PDF) |
| 9 | Evolutionary loss of inflammasomes in the Carnivora and implications for the carriage of zoonotic infections | 6.4 | 23 | Citations (PDF) |
| 10 | NETosis occurs independently of neutrophil serine proteases | 2.3 | 25 | Citations (PDF) |
| 11 | Multiplexed Probing of Proteolytic Enzymes Using Mass Cytometry-Compatible Activity-Based Probes | 15.7 | 29 | Citations (PDF) |
| 12 | Extended subsite profiling of the pyroptosis effector protein gasdermin D reveals a region recognized by inflammatory caspase-11 | 2.3 | 37 | Citations (PDF) |
| 13 | Endothelial activation of caspase-9 promotes neurovascular injury in retinal vein occlusion | 14.1 | 26 | Citations (PDF) |
| 14 | Detection of Active Granzyme A in NK92 Cells with Fluorescent Activity-Based Probe | 6.9 | 21 | Citations (PDF) |
| 15 | Classification and Nomenclature of Metacaspases and Paracaspases: No More Confusion with Caspases | 14.2 | 65 | Citations (PDF) |
| 16 | Noninvasive optical detection of granzyme B from natural killer cells with enzyme-activated fluorogenic probes | 2.3 | 28 | Citations (PDF) |
| 17 | Design, synthesis, and <i>in vitro</i> evaluation of aza-peptide aldehydes and ketones as novel and selective protease inhibitors | 5.3 | 8 | Citations (PDF) |
| 18 | Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy | 7.7 | 37 | Citations (PDF) |
| 19 | Selective inhibition of matrix metalloproteinase 10 (MMP10) with a single-domain antibody | 2.3 | 14 | Citations (PDF) |
| 20 | The Proteasome as a Drug Target in the Metazoan Pathogen, <i>Schistosoma mansoni</i> | 3.8 | 28 | Citations (PDF) |
| 21 | Fluorescent probes towards selective cathepsin B detection and visualization in cancer cells and patient samples | 7.5 | 53 | Citations (PDF) |
| 22 | Development of an advanced nanoformulation for the intracellular delivery of a caspase-3 selective activity-based probe | 5.1 | 5 | Citations (PDF) |
| 23 | The Pyroptotic Cell Death Effector Gasdermin D Is Activated by Gout-Associated Uric Acid Crystals but Is Dispensable for Cell Death and IL-1β Release | 0.6 | 99 | Citations (PDF) |
| 24 | Cathepsin G Inhibition by Serpinb1 and Serpinb6 Prevents Programmed Necrosis in Neutrophils and Monocytes and Reduces GSDMD-Driven Inflammation | 6.4 | 185 | Citations (PDF) |
| 25 | Potent and selective caspase-2 inhibitor prevents MDM-2 cleavage in reversine-treated colon cancer cells | 13.7 | 24 | Citations (PDF) |
| 26 | Exploring the prime site in caspases as a novel chemical strategy for understanding the mechanisms of cell death: a proof of concept study on necroptosis in cancer cells | 13.7 | 8 | Citations (PDF) |
| 27 | Cytosolic Gram-negative bacteria prevent apoptosis by inhibition of effector caspases through lipopolysaccharide | 12.8 | 34 | Citations (PDF) |
| 28 | Selective imaging of cathepsin L in breast cancer by fluorescent activity-based probes | 7.5 | 61 | Citations (PDF) |
| 29 | Extensive peptide and natural protein substrate screens reveal that mouse caspase-11 has much narrower substrate specificity than caspase-1 | 2.3 | 80 | Citations (PDF) |
| 30 | A primer on caspase mechanisms | 5.4 | 122 | Citations (PDF) |
| 31 | Protease Specificity: Towards In Vivo Imaging Applications and Biomarker Discovery | 8.1 | 51 | Citations (PDF) |
| 32 | Caspase selective reagents for diagnosing apoptotic mechanisms | 13.7 | 40 | Citations (PDF) |
| 33 | Highly sensitive and adaptable fluorescence-quenched pair discloses the substrate specificity profiles in diverse protease families | 3.7 | 53 | Citations (PDF) |
| 34 | Differing Requirements for MALT1 Function in Peripheral B Cell Survival and Differentiation | 0.6 | 10 | Citations (PDF) |
| 35 | Toolbox of Fluorescent Probes for Parallel Imaging Reveals Uneven Location of Serine Proteases in Neutrophils | 15.7 | 82 | Citations (PDF) |
| 36 | Apoptosis Activation in Human Lung Cancer Cell Lines by a Novel Synthetic Peptide Derived from Conus californicus Venom | 3.9 | 23 | Citations (PDF) |
| 37 | Protease signaling in animal and plant‐regulated cell death | 5.5 | 80 | Citations (PDF) |
| 38 | Counter Selection Substrate Library Strategy for Developing Specific Protease Substrates and Probes | 6.4 | 43 | Citations (PDF) |
| 39 | Response to Comment on “SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML” | 5.5 | 0 | Citations (PDF) |
| 40 | The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia | 13.1 | 146 | Citations (PDF) |
| 41 | Regulation of Histone Acetylation by Autophagy in Parkinson Disease | 2.3 | 129 | Citations (PDF) |
| 42 | The Paracaspase MALT1 | 3.0 | 36 | Citations (PDF) |
| 43 | Design of a Selective Substrate and Activity Based Probe for Human Neutrophil Serine Protease 4 | 2.5 | 48 | Citations (PDF) |
| 44 | SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML | 5.5 | 17 | Citations (PDF) |
| 45 | Probes to Monitor Activity of the Paracaspase MALT1 | 5.3 | 23 | Citations (PDF) |
| 46 | Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling | 40.1 | 2,693 | Citations (PDF) |
| 47 | Biochemical Characterization and Substrate Specificity of Autophagin-2 from the Parasite Trypanosoma cruzi | 2.3 | 7 | Citations (PDF) |
| 48 | Small Molecule Active Site Directed Tools for Studying Human Caspases | 54.6 | 67 | Citations (PDF) |
| 49 | Inducible dimerization and inducible cleavage reveal a requirement for both processes in caspase-8 activation. | 2.3 | 1 | Citations (PDF) |
| 50 | Staphylococcal SplB Serine Protease Utilizes a Novel Molecular Mechanism of Activation | 2.3 | 13 | Citations (PDF) |
| 51 | Design of ultrasensitive probes for human neutrophil elastase through hybrid combinatorial substrate library profiling | 7.7 | 145 | Citations (PDF) |
| 52 | A remarkable activity of human leukotriene A4 hydrolase (LTA4H) toward unnatural amino acids | 2.3 | 19 | Citations (PDF) |
| 53 | Regulated Cell Death: Signaling and Mechanisms | 10.1 | 225 | Citations (PDF) |
| 54 | Caspase Enzymology and Activation Mechanisms | 1.0 | 25 | Citations (PDF) |
| 55 | Functions of caspase 8: The identified and the mysterious | 6.5 | 109 | Citations (PDF) |
| 56 | Caspase Cleavage Sites in the Human Proteome: CaspDB, a Database of Predicted Substrates | 2.5 | 56 | Citations (PDF) |
| 57 | Expedient Synthesis of Highly Potent Antagonists of Inhibitor of Apoptosis Proteins (IAPs) with Unique Selectivity for ML-IAP | 3.9 | 30 | Citations (PDF) |
| 58 | Identification and Evaluation of Small Molecule Pan-Caspase Inhibitors in Huntington’s Disease Models | 5.3 | 0 | Citations (PDF) |
| 59 | Caspase Substrates and Inhibitors | 7.4 | 152 | Citations (PDF) |
| 60 | Cathepsin G 2013, , 2661-2666 | | 3 | Citations (PDF) |
| 61 | Cathepsin D Primes Caspase-8 Activation by Multiple Intra-chain Proteolysis | 2.3 | 45 | Citations (PDF) |
| 62 | Mitochondrial pathway of apoptosis is ancestral in metazoans | 7.7 | 95 | Citations (PDF) |
| 63 | Activity, Specificity, and Probe Design for the Smallpox Virus Protease K7L | 2.3 | 14 | Citations (PDF) |
| 64 | X-ray Crystal Structure and Specificity of the Plasmodium falciparum Malaria Aminopeptidase PfM18AAP | 4.2 | 34 | Citations (PDF) |
| 65 | S1 pocket fingerprints of human and bacterial methionine aminopeptidases determined using fluorogenic libraries of substrates and phosphorus based inhibitors | 3.0 | 19 | Citations (PDF) |
| 66 | Guidelines for the use and interpretation of assays for monitoring autophagy | 13.8 | 2,928 | Citations (PDF) |
| 67 | An Optimized Activity-Based Probe for the Study of Caspase-6 Activation | 5.3 | 45 | Citations (PDF) |
| 68 | Glycine Fluoromethylketones as SENP‐Specific Activity Based Probes | 2.7 | 29 | Citations (PDF) |
| 69 | Fingerprinting the Substrate Specificity of M1 and M17 Aminopeptidases of Human Malaria, Plasmodium falciparum | 2.5 | 65 | Citations (PDF) |
| 70 | FLIPL induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity | 3.9 | 189 | Citations (PDF) |
| 71 | SnapShot: CaspasesCell, 2011, 147, 476-476.e1 | 35.1 | 48 | Citations (PDF) |
| 72 | RIPK-Dependent Necrosis and Its Regulation by Caspases: A Mystery in Five Acts | 14.2 | 139 | Citations (PDF) |
| 73 | Human Caspases – Apoptosis and Inflammation Signaling Proteases 2011, , 1-10 | | 0 | Citations (PDF) |
| 74 | Catalytic activity of the caspase-8–FLIPL complex inhibits RIPK3-dependent necrosis | 40.1 | 1,063 | Citations (PDF) |
| 75 | Functional Characterization of a SUMO Deconjugating Protease of Plasmodium falciparum Using Newly Identified Small Molecule Inhibitors | 5.3 | 37 | Citations (PDF) |
| 76 | Development of Small Molecule Inhibitors and Probes of Human SUMO Deconjugating Proteases | 5.3 | 57 | Citations (PDF) |
| 77 | The Dynamics and Mechanism of SUMO Chain Deconjugation by SUMO-specific Proteases | 2.3 | 60 | Citations (PDF) |
| 78 | Intranasal Delivery of Caspase-9 Inhibitor Reduces Caspase-6-Dependent Axon/Neuron Loss and Improves Neurological Function after Stroke | 3.7 | 81 | Citations (PDF) |
| 79 | Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity | 7.7 | 109 | Citations (PDF) |
| 80 | Urm1 couples sulfur transfer to ubiquitin-like protein function in oxidative stress | 7.7 | 20 | Citations (PDF) |
| 81 | Targeting activated integrin αvβ3 with patient-derived antibodies impacts late-stage multiorgan metastasis | 2.9 | 12 | Citations (PDF) |
| 82 | Divide and die another day | 4.2 | 0 | Citations (PDF) |
| 83 | Identification and Evaluation of Small Molecule Pan-Caspase Inhibitors in Huntington's Disease Models | 5.3 | 48 | Citations (PDF) |
| 84 | Identification of very potent inhibitor of human aminopeptidase N (CD13) | 2.1 | 24 | Citations (PDF) |
| 85 | Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis | 40.1 | 890 | Citations (PDF) |
| 86 | Emerging principles in protease-based drug discovery | 39.3 | 460 | Citations (PDF) |
| 87 | Vaccinia Virus Protein F1L Is a Caspase-9 Inhibitor | 2.3 | 40 | Citations (PDF) |
| 88 | Inducible Dimerization and Inducible Cleavage Reveal a Requirement for Both Processes in Caspase-8 Activation | 2.3 | 166 | Citations (PDF) |
| 89 | Aminopeptidase Fingerprints, an Integrated Approach for Identification of Good Substrates and Optimal Inhibitors | 2.3 | 92 | Citations (PDF) |
| 90 | Regulation of the Apaf-1–caspase-9 apoptosome | 3.2 | 340 | Citations (PDF) |
| 91 | Transnitrosylation of XIAP Regulates Caspase-Dependent Neuronal Cell Death | 14.2 | 163 | Citations (PDF) |
| 92 | Streptolysin O Promotes Group A Streptococcus Immune Evasion by Accelerated Macrophage Apoptosis | 2.3 | 139 | Citations (PDF) |
| 93 | Structure of the Fas/FADD complex: A conditional death domain complex mediating signaling by receptor clustering | 3.2 | 30 | Citations (PDF) |
| 94 | Nicotinamide Rescues Human Embryonic Stem Cell-Derived Neuroectoderm from Parthanatic Cell Death | 3.3 | 32 | Citations (PDF) |
| 95 | Structural and kinetic determinants of protease substrates | 6.4 | 109 | Citations (PDF) |
| 96 | Protection from Isopeptidase-Mediated Deconjugation Regulates Paralog-Selective Sumoylation of RanGAP1 | 14.2 | 57 | Citations (PDF) |
| 97 | Human Caspases: Activation, Specificity, and Regulation | 2.3 | 571 | Citations (PDF) |
| 98 | Proteolytic needles in the cellular haystack | 7.3 | 4 | Citations (PDF) |
| 99 | Caspase Mechanisms | 0.0 | 186 | Citations (PDF) |
| 100 | Cysteine Cathepsins Trigger Caspase-dependent Cell Death through Cleavage of Bid and Antiapoptotic Bcl-2 Homologues | 2.3 | 324 | Citations (PDF) |
| 101 | Caspase-8 Cleaves Histone Deacetylase 7 and Abolishes Its Transcription Repressor Function | 2.3 | 41 | Citations (PDF) |
| 102 | Chapter 21 Caspase Assays: Identifying Caspase Activity and Substrates In Vitro and In Vivo | 1.0 | 29 | Citations (PDF) |
| 103 | The Fas–FADD death domain complex structure unravels signalling by receptor clustering | 40.1 | 312 | Citations (PDF) |
| 104 | Carboxyl-terminal Proteolytic Processing of CUX1 by a Caspase Enables Transcriptional Activation in Proliferating Cells | 2.3 | 39 | Citations (PDF) |
| 105 | Small Ubiquitin-related Modifier (SUMO)-specific Proteases | 2.3 | 130 | Citations (PDF) |
| 106 | Identification of Proteolytic Cleavage Sites by Quantitative Proteomics | 3.7 | 73 | Citations (PDF) |
| 107 | The apoptosome: signalling platform of cell death | 31.4 | 871 | Citations (PDF) |
| 108 | Caspase Inhibition, Specifically | 3.9 | 10 | Citations (PDF) |
| 109 | Design, Synthesis, and Evaluation of Aza-Peptide Michael Acceptors as Selective and Potent Inhibitors of Caspases-2, -3, -6, -7, -8, -9, and -10 | 6.9 | 60 | Citations (PDF) |
| 110 | The Apoptosome Activates Caspase-9 by Dimerization | 14.2 | 233 | Citations (PDF) |
| 111 | Engineered Hybrid Dimers: Tracking the Activation Pathway of Caspase-7 | 14.2 | 34 | Citations (PDF) |
| 112 | Identification of Early Intermediates of Caspase Activation Using Selective Inhibitors and Activity-Based Probes | 14.2 | 108 | Citations (PDF) |
| 113 | Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family | 5.3 | 681 | Citations (PDF) |
| 114 | The Human Anti-apoptotic Proteins cIAP1 and cIAP2 Bind but Do Not Inhibit Caspases | 2.3 | 302 | Citations (PDF) |
| 115 | Cytokine Response Modifier A Inhibition of Initiator Caspases Results in Covalent Complex Formation and Dissociation of the Caspase Tetramer | 2.3 | 26 | Citations (PDF) |
| 116 | Activity-based probes that target diverse cysteine protease families | 7.3 | 303 | Citations (PDF) |
| 117 | XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs | 7.4 | 340 | Citations (PDF) |
| 118 | Yersinia Phosphatase Induces Mitochondrially Dependent Apoptosis of T Cells | 2.3 | 25 | Citations (PDF) |
| 119 | Lack of involvement of strand s1′A of the viral serpin CrmA in anti-apoptotic or caspase-inhibitory functions | 2.7 | 2 | Citations (PDF) |
| 120 | Selective Disruption of Lysosomes in HeLa Cells Triggers Apoptosis Mediated by Cleavage of Bid by Multiple Papain-like Lysosomal Cathepsins | 2.3 | 398 | Citations (PDF) |
| 121 | Glycosylation Broadens the Substrate Profile of Membrane Type 1 Matrix Metalloproteinase | 2.3 | 76 | Citations (PDF) |
| 122 | An IAP-IAP Complex Inhibits Apoptosis | 2.3 | 308 | Citations (PDF) |
| 123 | Neutralization of Smac/Diablo by Inhibitors of Apoptosis (IAPs) | 2.3 | 94 | Citations (PDF) |
| 124 | Caspase activation – stepping on the gas or releasing the brakes? Lessons from humans and flies | 6.6 | 207 | Citations (PDF) |
| 125 | Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity | 33.4 | 375 | Citations (PDF) |
| 126 | The protein structures that shape caspase activity, specificity, activation and inhibition | 3.9 | 709 | Citations (PDF) |
| 127 | Aza-Peptide Michael Acceptors: A New Class of Inhibitors Specific for Caspases and Other Clan CD Cysteine Proteases | 6.9 | 75 | Citations (PDF) |
| 128 | Design, Synthesis, and Evaluation of Aza-Peptide Epoxides as Selective and Potent Inhibitors of Caspases-1, -3, -6, and -8 | 6.9 | 53 | Citations (PDF) |
| 129 | Mechanisms of caspase activation | 4.2 | 1,096 | Citations (PDF) |
| 130 | A Unified Model for Apical Caspase Activation | 14.2 | 789 | Citations (PDF) |
| 131 | Comparative Analysis of Apoptosis and Inflammation Genes of Mice and Humans | 4.6 | 100 | Citations (PDF) |
| 132 | XIAP-mediated Caspase Inhibition in Hodgkin's Lymphoma–derived B Cells | 8.1 | 117 | Citations (PDF) |
| 133 | Human Caspase-7 Activity and Regulation by Its N-terminal Peptide | 2.3 | 95 | Citations (PDF) |
| 134 | Sequential Autolytic Processing Activates the Zymogen of Arg-gingipain | 2.3 | 52 | Citations (PDF) |
| 135 | Ionomycin-activated Calpain Triggers Apoptosis | 2.3 | 177 | Citations (PDF) |
| 136 | Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis | 7.7 | 127 | Citations (PDF) |
| 137 | Aza-Peptide Epoxides: A New Class of Inhibitors Selective for Clan CD Cysteine Proteases | 6.9 | 59 | Citations (PDF) |
| 138 | Caspases: Keys in the Ignition of Cell Death | 54.6 | 268 | Citations (PDF) |
| 139 | Expression, Purification, and Characterization of Caspases | 3.5 | 31 | Citations (PDF) |
| 140 | Regulating Cysteine Protease Activity: Essential Role of Protease Inhibitors As Guardians and Regulators | 2.3 | 216 | Citations (PDF) |
| 141 | Reprieval from execution: the molecular basis of caspase inhibition | 8.1 | 152 | Citations (PDF) |
| 142 | Caspases on the brain | 3.3 | 102 | Citations (PDF) |
| 143 | Caspases: opening the boxes and interpreting the arrows | 13.7 | 243 | Citations (PDF) |
| 144 | IAP proteins: blocking the road to death's door | 31.4 | 1,529 | Citations (PDF) |
| 145 | Direct Cleavage of AMPA Receptor Subunit GluR1 and Suppression of AMPA Currents by Caspase-3 | 3.7 | 57 | Citations (PDF) |
| 146 | Caspases and apoptosis | 5.3 | 155 | Citations (PDF) |
| 147 | Structural Basis for the Inhibition of Caspase-3 by XIAP | 35.1 | 662 | Citations (PDF) |
| 148 | The Serpins Are an Expanding Superfamily of Structurally Similar but Functionally Diverse Proteins | 2.3 | 1,027 | Citations (PDF) |
| 149 | Caspase-3-mediated Processing of Poly(ADP-ribose) Glycohydrolase during Apoptosis | 2.3 | 106 | Citations (PDF) |
| 150 | TRAF1 Is a Substrate of Caspases Activated during Tumor Necrosis Factor Receptor-α-induced Apoptosis | 2.3 | 59 | Citations (PDF) |
| 151 | Lysosomal Protease Pathways to Apoptosis | 2.3 | 561 | Citations (PDF) |
| 152 | A lysosomal protease enters the death scene | 9.1 | 57 | Citations (PDF) |
| 153 | Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8 | 3.9 | 272 | Citations (PDF) |
| 154 | Viral Caspase Inhibitors CrmA and p35 | 1.0 | 28 | Citations (PDF) |
| 155 | A second cytotoxic proteolytic peptide derived from amyloid β-protein precursor | 25.6 | 365 | Citations (PDF) |
| 156 | ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas | 3.9 | 357 | Citations (PDF) |
| 157 | Crystal structure of the apoptotic suppressor CrmA in its cleaved form | 3.9 | 55 | Citations (PDF) |
| 158 | Caspase Assays | 1.0 | 87 | Citations (PDF) |
| 159 | Caspase-9 Can Be Activated without Proteolytic Processing | 2.3 | 414 | Citations (PDF) |
| 160 | Cleavage of Atrophin-1 at Caspase Site Aspartic Acid 109 Modulates Cytotoxicity | 2.3 | 94 | Citations (PDF) |
| 161 | Cleavage of Automodified Poly(ADP-ribose) Polymerase during Apoptosis | 2.3 | 393 | Citations (PDF) |
| 162 | Kennedy's Disease | 4.0 | 192 | Citations (PDF) |
| 163 | Title is missing! | 3.4 | 143 | Citations (PDF) |
| 164 | Caspase 8: igniting the death machine | 3.9 | 35 | Citations (PDF) |
| 165 | Solution Structure of BID, an Intracellular Amplifier of Apoptotic Signaling | 35.1 | 431 | Citations (PDF) |
| 166 | Regulation of Cell Death Protease Caspase-9 by Phosphorylation | 38.2 | 2,545 | Citations (PDF) |
| 167 | The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis | 40.1 | 368 | Citations (PDF) |
| 168 | Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death | 13.7 | 163 | Citations (PDF) |
| 169 | Investigation of glucocorticoid-induced apoptotic pathway: Processing of Caspase-6 but not Caspase-3 | 13.7 | 49 | Citations (PDF) |
| 170 | Granzyme Release and Caspase Activation in Activated Human T-Lymphocytes | 2.3 | 114 | Citations (PDF) |
| 171 | Caspase-14 Is a Novel Developmentally Regulated Protease | 2.3 | 119 | Citations (PDF) |
| 172 | A Single BIR Domain of XIAP Sufficient for Inhibiting Caspases | 2.3 | 497 | Citations (PDF) |
| 173 | Granzyme B Mimics Apical Caspases | 2.3 | 136 | Citations (PDF) |
| 174 | Caspase Cleavage of Gene Products Associated with Triplet Expansion Disorders Generates Truncated Fragments Containing the Polyglutamine Tract | 2.3 | 475 | Citations (PDF) |
| 175 | Pro-caspase-3 Is a Major Physiologic Target of Caspase-8 | 2.3 | 626 | Citations (PDF) |
| 176 | An Induced Proximity Model for Caspase-8 Activation | 2.3 | 843 | Citations (PDF) |
| 177 | Target Protease Specificity of the Viral Serpin CrmA | 2.3 | 478 | Citations (PDF) |
| 178 | Caspase Cleavage of Keratin 18 and Reorganization of Intermediate Filaments during Epithelial Cell Apoptosis | 4.8 | 536 | Citations (PDF) |
| 179 | Zinc Is a Potent Inhibitor of the Apoptotic Protease, Caspase-3 | 2.3 | 416 | Citations (PDF) |
| 180 | FLICE Induced Apoptosis in a Cell-free System | 2.3 | 306 | Citations (PDF) |
| 181 | The Regulation of Anoikis: MEKK-1 Activation Requires Cleavage by Caspases | 35.1 | 466 | Citations (PDF) |
| 182 | Caspases: Intracellular Signaling by Proteolysis | 35.1 | 1,927 | Citations (PDF) |
| 183 | Biochemical Characteristics of Caspases-3, -6, -7, and -8 | 2.3 | 462 | Citations (PDF) |
| 184 | X-linked IAP is a direct inhibitor of cell-death proteases | 40.1 | 1,701 | Citations (PDF) |
| 185 | Granzyme B/Perforin-Mediated Apoptosis of Jurkat Cells Results in Cleavage of Poly(ADP-ribose) Polymerase to the 89-kDa Apoptotic Fragment and Less Abundant 64-kDa Fragment | 2.1 | 97 | Citations (PDF) |
| 186 | Human ICE/CED-3 Protease Nomenclature | 35.1 | 1,966 | Citations (PDF) |
| 187 | Interaction of subtilisins with serpins | 5.9 | 22 | Citations (PDF) |
| 188 | Serpin α<sub>1</sub>proteinase inhibitor probed by intrinsic tryptophan fluorescence spectroscopy | 5.9 | 23 | Citations (PDF) |
| 189 | Molecular Ordering of Apoptotic Mammalian CED-3/ICE-like Proteases | 2.3 | 174 | Citations (PDF) |
| 190 | α1-Microglobulin Destroys the Proteinase Inhibitory Activity of α1-Inhibitor-3 by Complex Formation | 2.3 | 10 | Citations (PDF) |
| 191 | Granzyme B Is Inhibited by the Cowpox Virus Serpin Cytokine Response Modifier A | 2.3 | 194 | Citations (PDF) |
| 192 | Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase | 35.1 | 2,259 | Citations (PDF) |
| 193 | [7] α-Macroglobulins: Detection and characterization | 1.0 | 46 | Citations (PDF) |
| 194 | Expression of a functional α-macroglobulin receptor binding domain inEscherichia coli | 2.8 | 20 | Citations (PDF) |
| 195 | Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme | 35.1 | 900 | Citations (PDF) |
| 196 | Substrate specificities and activation mechanisms of matrix metalloproteinases | 4.2 | 162 | Citations (PDF) |
| 197 | Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts | 0.3 | 369 | Citations (PDF) |
| 198 | [21] Human kininogens | 1.0 | 36 | Citations (PDF) |
| 199 | cDNA encoding a human homolog of yeast ubiquitin 1 | 16.2 | 37 | Citations (PDF) |
| 200 | Rapid isolation of human kininogens | 2.4 | 37 | Citations (PDF) |
| 201 | INTERACTION OF ?2-MACROGLOBULIN WITH NEUTROPHIL AND PLASMA PROTEINASES | 4.5 | 26 | Citations (PDF) |
| 202 | Comparison of the Structure and Aspects of the Proteinase-Binding Properties of Cystic Fibrotic α2-Macroglobulin with Normal α2-Macroglobulin | 2.1 | 8 | Citations (PDF) |
